addressalign-toparrow-leftarrow-rightbackbellblockcalendarcameraccwchatcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-crosscrosseditemptyheartfacebookfolderfullheartglobegmailgoogleimagesinstagramlinklocation-pinmagnifying-glassmailminusmoremuplabelShape 3 + Rectangle 1outlookpersonplusprice-ribbonImported LayersImported LayersImported Layersshieldstartrashtriangle-downtriangle-uptwitteruseryahoo

Dr. Justin Boyd Harvard NeuroDiscovery Center Scientist

Dr. Justin D. Boyd is drug discovery scientist interested in developing high efficiency and high efficacy platforms for early and late stage drug discovery. Platforms include high performance computation for virtual screening and molecular dynamics; high content analysis for cell-based phenotypic screening; and surrogate cellular assays for biomarker analysis for in vivo drug efficacy. He is the Co-Founder and Chair of the Board of the Chattanooga Research Institute (CRI) and is a Leads Discovery Scientist in the Laboratory of Drug Discovery in Neurodegeneration, an affiliate lab of the Harvard NeuroDiscovery Center. Prior to his current positions, Dr. Boyd worked at the National Institutes of Health as a visiting Scientist for Evotec, a German pharmaceutical company, and as a Postdoctoral Fellow in the Laboratory of Molecular Biology at the National Institute for Neurological Disorders and Stroke. Dr. Boyd has a Ph.D. in Interdisciplinary Sciences with a specialty in Neuroscience from the University of Tennessee Health Science Center and a Bachelor of Science in Biology from Rhodes College.

As CRI’s Co-Founder and Chair of the Board, Dr. Boyd is responsible for the launch of CRI’s platform developments through academic and business partnerships. At Harvard, Dr. Boyd directs the High Content Imaging and Analysis program and is developing ex vivo biomarker analytical assays to monitor drug efficacy. Dr. Boyd is also a technology consultant for the biotech and pharmaceutical industries in the greater Boston area.

Dr. Boyd has thirteen years experience in research in neuroscience and six years experience in stem cell research and drug discovery. He is published in the fields of neurobiology, stem cell biology, infectious disease and drug discovery, reflecting his strong experience in interdisciplinary approaches to research.

-Dr. Justin Boyd
Chattanooga Research Institute
Laboratory of Drug Discovery in Neurodegeneration
Harvard NeuroDiscovery Center
Department of Neurology
Brigham and Women’s Hospital
Harvard Medical School

Join or login to comment.

  • A former member
    A former member

    Very interesting talk. If successful this could speed up the drug discovery process. Too bad it was karaoke night.

    April 3, 2012

9 went

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy